Financial statements Nanovelos
Balance sheet data of NANOVELOS
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 8 766 737,10 | 220 880,85 |
| A. Fixed assets | 8 453 232,56 | 62 955,43 |
| B. Current assets | 313 504,54 | 157 925,42 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 8 766 737,10 | 220 880,85 |
| A. Equity | 529 160,74 | -2 462 792,11 |
| B. Liabilities and provisions for liabilities | 8 237 576,36 | 2 683 672,96 |
| I. Long-term liabilities | 2 419 167,81 | 2 564 376,23 |
| II. Short-term liabilities | 40 586,67 | 97 898,85 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.